Patricia
Muñoz
Publicacións nas que colabora con Patricia Muñoz (18)
2023
-
Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms
Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922
-
Rapid Discrimination of Pseudomonas aeruginosa ST175 Isolates Involved in a Nosocomial Outbreak Using MALDI-TOF Mass Spectrometry and FTIR Spectroscopy Coupled with Machine Learning
Transboundary and Emerging Diseases, Vol. 2023
-
Validation of an expanded, in-house library and an optimized preparation method for the identification of fungal isolates using MALDI-TOF mass spectrometry
Medical mycology, Vol. 61, Núm. 4
2022
-
Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266
-
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers
Microbiology Spectrum, Vol. 10, Núm. 1
-
Rapid and Reproducible MALDI‐TOF‐Based Method for the Detection of Vancomycin‐Resistant Enterococcus faecium Using Classifying Algorithms
Diagnostics, Vol. 12, Núm. 2
2021
-
Inference of active viral replication in cases with sustained positive reverse transcription-PCR results for SARS-CoV-2
Journal of Clinical Microbiology, Vol. 59, Núm. 2
-
Invasive pulmonary aspergillosis in the COVID-19 era: An expected new entity
Mycoses, Vol. 64, Núm. 2, pp. 132-143
-
Shared mutations in emerging SARS-CoV-2 circulating variants may lead to reverse transcription-PCR (RT-PCR)-based misidentification of B.1.351 and P.1 variants of concern
Microbiology Spectrum, Vol. 9, Núm. 2
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
2014
-
Prevention strategies for cytomegalovirus disease and long-term outcomes in the high-risk transplant patient (D+/R-): Experience from the RESITRA-REIPI cohort
Transplant Infectious Disease, Vol. 16, Núm. 3, pp. 387-396
2012
-
Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort
Transplant Infectious Disease, Vol. 14, Núm. 6, pp. 595-603
-
Outcome of Clostridium difficile-associated disease in solid organ transplant recipients: A prospective and multicentre cohort study
Transplant International, Vol. 25, Núm. 12, pp. 1275-1281
2009
-
Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the resitra (spanish network of infection in transplantation) cohort
Clinical Infectious Diseases, Vol. 48, Núm. 12, pp. 1657-1665
2008
-
Donor infection and transmission to the recipient of a solid allograft
American Journal of Transplantation, Vol. 8, Núm. 11, pp. 2420-2425
-
Impact of current transplantation management on the development of cytomegalovirus disease after renal transplantation
Clinical Infectious Diseases, Vol. 47, Núm. 7, pp. 875-882
-
Incisional surgical infection in heart transplantation
Transplant Infectious Disease, Vol. 10, Núm. 4, pp. 298-302
-
Valganciclovir as treatment for cytomegalovirus disease in solid organ transplant recipients
Clinical Infectious Diseases, Vol. 46, Núm. 1, pp. 20-27